Osaka Kyousei Dental Group Honored as Japan's Longest-Serving Invisalign Provider. Recognized for 20 Years of Progress and 7 Consecutive Years of Top-Tier Status.

Medical Corporation Shinshikai Osaka Kyousei Dental Group / Clover Dental & Orthodontic Dental Clinic (Base: Osaka City, Chairman: Masahiro Matsumoto) announces that it has been awarded by Invisalign Japan Inc. and Align Technology, Inc. (USA) as the 'longest-serving Invisalign provider in Japan.'

At the 'Align GP Prestige 2026' event held on February 28, 2026, to commemorate the 20th anniversary of Invisalign's introduction to Japan, the group was awarded the prestigious 'Valued Long-Term Provider' in recognition of their long-standing contribution to its popularization and their overwhelming clinical experience exceeding 12,000 cases.

Award Background: 20 Years from the Dawn of Clear Aligners in Japan The group was highly evaluated for its track record of engaging in treatments since the early stages of Invisalign's introduction to Japan and leading the clear aligner orthodontic field in the country to this day.

On the screen at the stage, General Director Masahiro Matsumoto's name was prominently displayed as a 'Valued Long-Term Provider', and a certificate honoring his past achievements was presented by Joe Hogan, CEO of Align Technology, Inc. (USA).

'Invisalign is merely a tool' - High-Quality Treatment Brought by Clinical Experience Our group has been conducting treatments based on the belief that 'the device (Invisalign) is strictly a tool, and the success or failure of the treatment depends on the precise treatment plan (ClinCheck) by the dentist.'

- Leading number of cases in Japan: Capable of handling complex cases based on a track record of treating over 12,000 people cumulatively. - 7 consecutive years of top evaluation: Awarded the 'Purple Diamond Provider', given only to clinics with over 1,500 cases annually. - Utilization of the latest technology: Achieved a reduction in clinic visits (average of one visit every 4 to 6 months) and a shortened treatment period (reduced by about 30%) through 'Virtual Care' using an AI app.